Abstract
In this chapter we will briefly reiterate critical aspects of solution nuclear magnetic resonance (NMR) spectroscopy approaches and their applications in drug discovery. These approaches are essentially based on a number of NMR techniques that have been developed to monitor and characterize intermolecular interactions. By way of examples, we will illustrate the unique advantages that these techniques offer when employed in conjunction with fragment-based ligand design, especially when tackling challenging drug targets.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pellecchia M, Sem DS, Wuthrich K (2002) Nat Rev Drug Discov 1:211
Pellecchia M (2005) Chem Biol 12:961-971
Pellecchia M, Becattini B, Crowell KJ, Fattorusso R, Forino M, Fragai M, Jung D, Mustelin T, Tautz L (2004) Expert Opin Ther Targets 8:597
Papeo G, Giordano P, Brasca MG, Buzzo F, Caronni D, Ciprandi F, Mongelli N, Veronesi M, Vulpetti A, Dalvit C (2007) J Am Chem Soc 129:5665
Dalvit C, Ardini E, Flocco M, Fogliatto GP, Mongelli N, Veronesi M (2003) J Am Chem Soc 125:14620
Hajduk PJ, Burns DJ (2002) Comb Chem High Throughput Screen 5:613
Hajduk PJ, Greer J (2007) Nat Rev Drug Discov 6:211
Jahnke W, Erlanson DA (2006) Fragment-based approaches in drug discovery. Wiley, New York
Valler MJ, Green D (2000) Drug Discov Today 5:286
Vogtherr M, Saxena K, Hoelder S, Grimme S, Betz M, Schieborr U, Pescatore B, Robin M, Delarbre L, Langer T, Wendt KU, Schwalbe H (2006) Angew Chem Int Ed Engl 45:993
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Adv Drug Deliv Rev 46:3
Lipinski CA (2003) Drug Discov Today 8:12
Lipinski CA (2000) J Pharmacol Toxicol Methods 44:235
Carr RA, Congreve M, Murray CW, Rees DC (2005) Drug Discov Today 10:987
Congreve M, Carr R, Murray C, Jhoti H (2003) Drug Discov Today 8:876
Erlanson DA, Hansen SK (2004) Curr Opin Chem Biol 8:399
Erlanson DA, McDowell RS, O'Brien T (2004) J Med Chem 47:3463
Erlanson DA, Wells JA, Braisted AC (2004) Annu Rev Biophys Biomol Struct 33:199
Gill A, Cleasby A, Jhoti H (2005) Chembiochem 6:506
Hartshorn MJ, Murray CW, Cleasby A, Frederickson M, Tickle IJ, Jhoti H (2005) J Med Chem 48:403
Moore WR Jr (2005) Curr Opin Drug Discov Devel 8:355
Rees DC, Congreve M, Murray CW, Carr R (2004) Nat Rev Drug Discov 3:660
Schade M, Oschkinat H (2005) Curr Opin Drug Discov Devel 8:365
Villar HO, Yan J, Hansen MR (2004) Curr Opin Chem Biol 8:387
Zartler ER, Shapiro MJ (2005) Curr Opin Chem Biol 9:366
Shuker SB, Hajduk PJ, Meadows RP, Fesik SW (1996) Science 274:1531
Langer T, Vogtherr M, Elshorst B, Betz M, Schieborr U, Saxena K, Schwalbe H (2004) Chembiochem 5:1508
Allen KN, Lavie A, Petsko GA, Ringe D (1995) Biochemistry 34:3742
Rutenber E, Fauman EB, Keenan RJ, Fong S, Furth PS, Ortiz de Montellano PR, Meng E, Kuntz ID, DeCamp DL, Salto R et al. (1993) J Biol Chem 268:15343
Rutenber EE, McPhee F, Kaplan AP, Gallion SL, Hogan JC Jr, Craik CS, Stroud RM (1996) Bioorg Med Chem 4:1545
Shoichet BK, Stroud RM, Santi DV, Kuntz ID, Perry KM (1993) Science 259:1445
Verlinde CLMJ, Pijning T, Kalk KH, van Calenbergh S, Aershot AV, Herdewijn P, Callens M, Michels P, Opperdoes FR, Wierenga RK, Hol WGJ (1993) In: Testa B, Kyburz E, Fuhrer W, Giger R (eds) Perspectives in medicinal chemistry. Helvetica Chimica Acta, Basel, p 135
Bertini I, Del Bianco C, Gelis I, Katsaros N, Luchinat C, Parigi G, Peana M, Provenzani A, Zoroddu MA (2004) Proc Natl Acad Sci U S A 101:6841
Hajduk PJ, Gerfin T, Boehlen JM, Haberli M, Marek D, Fesik SW (1999) J Med Chem 42:2315
Jahnke W (2007) J Biomol NMR 39:87
Kessler H, Klages J (2006) In: Triggle DJ, Taylor JB (eds) Comprehensive medicinal chemistry II, vol 3. Elsevier, Oxford, p 901
Klages J, Coles M, Kessler H (2006) In: Bartlett PA, Etzeroth M (eds) NMR-based screening in exploiting chemical diversity for drug discovery, vol 12. RSC, Cambridge, UK, p 263
Klages J, Coles M, Kessler H (2006) NMR-based screening. RSC, Cambridge, UK
Klages J, Coles M, Kessler H (2007) Analyst 132:693
Coles M, Heller M, Kessler H (2003) Drug Discov Today 8:803
Neumann T, Junker HD, Schmidt K, Sekul R (2007) Curr Top Med Chem 7:1630
Fejzo J, Lepre CA, Peng JW, Bemis GW, Ajay, Murcko MA, Moore JM (1999) Chem Biol 6:755
Kuntz ID, Chen K, Sharp KA, Kollman PA (1999) Proc Natl Acad Sci U S A 96:9997
Hopkins AL, Groom CR, Alex A (2004) Drug Discov Today 9:430
Cele AZ, Metz JT (2005) Drug Discov Today 10:464
Hajduk PJ (2006) J Med Chem 49:6972
Hajduk PJ, Sheppard G, Nettesheim DG, Olejniczak ET, Shuker SB, Meadows RP, Steinman DH, Carrera GM, Marcotte PA, Severin J, Walter K, Smith H, Gubbins E, Simmer R, Holzman TF, Morgan DW, Davidsen SK, Summers JB, Fesik SW (1997) J Am Chem Soc 119:5818
Rega MF, Leone M, Jung D, Cotton NJ, Stebbins JL, Pellecchia M (2007) Bioorg Chem 35:344
Pervushin K, Riek R, Wider G, Wuthrich K (1997) Proc Natl Acad Sci U S A 94:12366
Pellecchia M, Meininger D, Dong Q, Chang E, Jack R, Sem DS (2002) J Biomol NMR 22:165
Wyss DF, McCoy MA, Senior MM (2002) Curr Opin Drug Discov Devel 5:630
Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, Joseph MK, Kitada S, Korsmeyer SJ, Kunzer AR, Letai A, Li C, Mitten MJ, Nettesheim DG, Ng S, Nimmer PM, O'Connor JM, Oleksijew A, Petros AM, Reed JC, Shen W, Tahir SK, Thompson CB, Tomaselli KJ, Wang B, Wendt MD, Zhang H, Fesik SW, Rosenberg SH (2005) Nature 435:677
Hajduk PJ, Olejniczak ET, Fesik SW (1997) J Am Chem Soc 119:12257
Klein J, Meinecke R, Mayer M, Meyer B (1999) J Am Chem Soc 121:5336
Mayer M, Meyer B (1999) Angew Chem Int Ed 38:1784
Dalvit C, Pevarello P, Tato M, Veronesi M, Vulpetti A, Sundstrom M (2000) J Biomol NMR 18:65
Dalvit C, Flocco M, Stockman BJ, Veronesi M (2002) Comb Chem High Throughput Screen 5:645
Dalvit C, Hadden DT, Sarver RW, Ho AM, Stockman BJ (2003) Comb Chem High Throughput Screen 6:445
Mayer M, Meyer B (2001) J Am Chem Soc 123:6108
Meinecke R, Meyer B (2001) J Med Chem 44:3059
Leone M, Freeze HH, Chan CS, Pellecchia M (2006) Curr Drug Discov Technol 3:91
Becattini B, Pellecchia M (2006) Chemistry 12:2658
Becattini B, Sareth S, Zhai D, Crowell KJ, Leone M, Reed JC, Pellecchia M (2004) Chem Biol 11:1107
Chen J, Zhang Z, Stebbins JL, Zhang X, Hoffman R, Moore A, Pellecchia M (2007) ACS Chem Biol 2:329
Becattini B, Culmsee C, Leone M, Zhai D, Zhang X, Crowell KJ, Rega MF, Landshamer S, Reed JC, Plesnila N, Pellecchia M (2006) Proc Natl Acad Sci U S A 103:12602
Jahnke W, Rudisser S, Zurini M (2001) J Am Chem Soc 123:3149
Jahnke W, Lawrence B, Perez L, Paris G, Strauss A, Fendrich G, Nalin CM (2000) J Am Chem Soc 122:7394
Vazquez J, De SK, Chen LH, Riel-Mehan M, Emdadi A, Cellitti J, Stebbins JL, Rega MF, Pellecchia M (2008) J Med Chem 51:3460-3465
Vazquez J, Tautz L, Ryan JJ, Vuori K, Mustelin T, Pellecchia M (2007) J Med Chem 50:2137
Acknowledgments
Several review articles cover in much greater details numerous NMR applications that have been reported in the past years on the use of NMR spectroscopy in the drug discovery process and to monitor target-ligand interactions. The author apologizes if he was unable to mention properly all this work within the limited space of this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Pellecchia, M. (2009). NMR Spectroscopy in Fragment Based Drug Design. In: Hayward, M.M., et al. Lead-Seeking Approaches. Topics in Medicinal Chemistry, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/7355_2009_5
Download citation
DOI: https://doi.org/10.1007/7355_2009_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-01074-3
Online ISBN: 978-3-642-01075-0
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)